, Health and Social Care Committee
Gynaecological cancers: Panel 6
And how do we do that?
, Health and Social Care Committee
Gynaecological cancers: Panel 6
We like to talk about data. [Laughter.]
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Thank you, Jack. Are there any other final questions from Members, or any other final comments that the panel would like to leave us with, or perhaps anything you think would be useful for our inquiry that's not been drawn out through questions today?
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Thank you, and some of the background was very useful there, Professor Doull. Thank you. Jack Sargeant.
, Health and Social Care Committee
Gynaecological cancers: Panel 6
That's helpful. Thank you.
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Professor Doull, probably.
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Thanks, Rhun. Joyce, you wanted to come in, and come on to your section after that as well. Joyce.
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Thank you. That's really helpful. Rhun ap Iorwerth.
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Thank you. I should say, Professor Doull, there are some specific questions for you later on in this session. I don't want you to feel left out.
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Okay. There we are. That's on the record. Thank you. Sarah Murphy.
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Is there scope for Wales to be a test bed, then, in that regard?
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Right. Okay.
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Thank you. We're short of time. I just want to squeeze one question in, and just a brief answer, I hope. What research is under way in Wales to look at therapeutic vaccines for gynaecological cancers?
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Iolo Doull, you wanted to come in.
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Sadie.
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Okay, thank you. That's really helpful. Can I just ask—? We've got a lot of questions to get through. Do you mind if Members politely interrupt, just to make sure we get through all our questions? Lovely, thank you. Gareth Davies.
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Can I just bring Jack in? Jack.
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Thank you. Sorry, do you want to come in, Joyce? Joyce Watson.
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Yes. Is there anything else you can suggest in terms of speeding up, I suppose, health research and medical breakthroughs?
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Thank you, Sadie. To Andy Glyde, I suppose a similar question to you, just to provoke discussion here. So, Cancer Research UK, you spend £388 million—or you did spend that, back in 2021-22—but there's only a small element, I think it's about 3 per cent, spent…
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Thank you, Sadie. You also mentioned in your—. I'm looking at your latest annual report. You provide examples of research you are undertaking in relation to lung cancer and bowel cancer, et cetera, but there's no mention of any specific work relating to…
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Lovely. Thank you all for being with us this morning. Perhaps I can just ask a question to you, Sadie, first of all. So, the Wales Cancer Research Centre, you've received Welsh Government funding of £5 million. I think that's up to 2026. How is that funding…
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Thank you, Sadie.
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Sadie.
, Health and Social Care Committee
Gynaecological cancers: Panel 6
Welcome back to the Health and Social Care Committee. We move to item 6, and this is our next session—or panel 6—on our gynaecological cancers inquiry. So, I'm grateful for our witnesses before us this morning. Perhaps you could just introduce yourselves for…
